{"id":187941,"date":"2026-08-06T10:26:20","date_gmt":"2026-08-06T04:56:20","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=187941"},"modified":"2026-08-06T10:26:20","modified_gmt":"2026-08-06T04:56:20","slug":"pharmaids-pharmaceuticals-ltd-share-price-rise-2026-08-06","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pharmaids-pharmaceuticals-ltd-share-price-rise-2026-08-06\/","title":{"rendered":"Pharmaids Pharmaceuticals Ltd. (PHARMAID): Pharmaids Pharmaceuticals Share Price Rises 8.39% Today"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Pharmaids Pharmaceuticals Share Price rises 8.39% today to Rs 34.9, with a market cap of Rs 114.66 crore.<\/p>\n<p style=\"margin-top:0!important;\">Pharmaids Pharmaceuticals Share Price has seen a notable increase today, rising by 8.39% to reach Rs 34.9. This significant gain places the company in the spotlight within the micro-cap category, where it currently holds a market capitalisation of Rs 114.66 crore. <\/p>\n<p>Today&#8217;s price movement is significant for Pharmaids Pharmaceuticals, a company operating in the Healthcare sector, specifically within the Pharmaceuticals &#038; Drugs industry. The increase in share price is a key event for investors tracking the stock, as it reflects a positive shift in market sentiment. While the data confirms the price rise, it does not establish a specific company-related catalyst for this movement.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Pharmaids_Pharmaceuticals_Ltd_PHARMAID_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Pharmaids Pharmaceuticals Ltd. (PHARMAID) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 34.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 32.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 2.7 (+8.39%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 33.14<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 36.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 33.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19,298<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19,298<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19,298<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.07 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 114.66 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Micro Cap<\/td>\n<\/tr>\n<\/table>\n<p>Pharmaids Pharmaceuticals Ltd. (PHARMAID) traded at Rs 34.9. versus the previous close of Rs 32.2, a rise of 8.39%. The stock opened at Rs 33.14, reached Rs 36.04, touched Rs 33.05. Reported volume was 19,298.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Pharmaids_Pharmaceuticals_Ltd_PHARMAID_Fundamental_Analysis\"><\/span><strong>Pharmaids Pharmaceuticals Ltd. (PHARMAID) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 114.66 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-10.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -3.32<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Pharmaids Pharmaceuticals Ltd. was valued at a P\/E ratio of -10.51x, a P\/B ratio of 2.38x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 1.1% and ROCE of 1.04%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<p>Per-share and shareholder-return metrics included EPS of Rs -3.32, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.<\/p>\n<p>Pharmaids Pharmaceuticals, with a market capitalisation of Rs 114.66 crore, operates within the Healthcare sector. The company&#8217;s financial metrics provide a mixed picture of its current valuation and performance. The P\/E ratio stands at -10.51, indicating that the company is currently not profitable, as earnings per share (EPS) is -3.32. This negative EPS reflects a challenging financial position.<\/p>\n<p>The P\/B ratio is 2.38, which is above the industry median of 1.86, suggesting that the stock may be valued higher relative to its book value compared to its peers. The return on equity (ROE) is 1.1%, and the return on capital employed (ROCE) is 1.04%, both of which are below the industry averages, indicating lower profitability and efficiency.<\/p>\n<p>Pharmaids Pharmaceuticals does not offer a dividend yield, which may be a consideration for income-focused investors. The company&#8217;s current financial performance highlights the need for careful evaluation of its growth prospects and market positioning.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-10.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">81.19x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.23x to 3,428.55x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.86x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.59%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.98%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 114.66 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 145.72 crore<\/td>\n<\/tr>\n<\/table>\n<p>Pharmaids Pharmaceuticals Ltd. (PHARMAID) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Pharmaids Pharmaceuticals Ltd. (PHARMAID) has a P\/E ratio of -10.51x, which is below the benchmark median of 26.22x, a difference of -140.08%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Pharmaids Pharmaceuticals Ltd. (PHARMAID) has a ROE of 1.1%, which is below the benchmark median of 10.59%, a difference of -89.61%. Pharmaids Pharmaceuticals Ltd. (PHARMAID) has a ROCE of 1.04%, which is below the benchmark median of 12.98%, a difference of -91.99%.<\/p>\n<p>Track today&#8217;s top gainers through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>The P\/B ratio of 2.38 is slightly above the industry median of 1.86, suggesting a higher valuation relative to book value. The company&#8217;s ROE of 1.1% and ROCE of 1.04% are both below the industry averages, reflecting lower returns on equity and capital employed.<\/p>\n<p>With a market cap of Rs 114.66 crore, Pharmaids Pharmaceuticals is positioned below the industry median of Rs 145.72 crore. This places the company in the lower range of the market-cap spectrum within its industry, highlighting the competitive landscape it operates in.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,943.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">31.4<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,812.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,684.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.39<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,621.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">63.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.01<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/panaceabio\/panacea-biotec-ltd-share-price-today\"><strong>Panacea Biotec Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PANACEABIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,566.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<\/tr>\n<\/table>\n<p>Pharmaids Pharmaceuticals Ltd. (PHARMAID) has a P\/E ratio of -10.51x compared with the displayed peer median of 31.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 1.1% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 1.04% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. Pharmaids Pharmaceuticals Ltd. (PHARMAID) has a market capitalisation of Rs 114.66 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<p>In comparison to its peers, Pharmaids Pharmaceuticals shows distinct differences in financial metrics. Dishman Carbogen Amcis Ltd. has a P\/E of 31.4, while Pharmaids&#8217; P\/E is -10.51, indicating a lack of profitability. Hikal Ltd. has a P\/B of 2.39, similar to Pharmaids&#8217; 2.38, but with stronger ROE and ROCE figures.<\/p>\n<p>Kwality Pharmaceuticals Ltd. and Beta Drugs Ltd. both exhibit higher P\/E ratios and ROE, indicating stronger financial performance. These comparisons highlight the challenges Pharmaids Pharmaceuticals faces in achieving profitability and improving its financial metrics relative to its peers.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Pharmaids_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Pharmaids Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors are closely monitoring Pharmaids Pharmaceuticals due to its recent price rise and market activity. The stock&#8217;s performance today has drawn attention, and several factors are contributing to this interest:<\/p>\n<ul>\n<li><strong>Price Action:<\/strong> Significant 8.39% rise in share price today.<\/li>\n<li><strong>Technical Position:<\/strong> RSI indicates weak momentum, suggesting cautious optimism.<\/li>\n<li><strong>Fundamental Context:<\/strong> Negative EPS and low ROE highlight financial challenges.<\/li>\n<li><strong>Sector Positioning:<\/strong> Operates in a competitive Pharmaceuticals &#038; Drugs industry.<\/li>\n<\/ul>\n<p>Investors should continue to monitor Pharmaids Pharmaceuticals for any developments that may impact its financial performance and market position. The company&#8217;s ability to improve profitability and strengthen its market presence will be key factors to watch.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Pharmaids_Pharmaceuticals\"><\/span><strong>About Pharmaids Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharmaids Pharmaceuticals Ltd. operates in the Healthcare sector, focusing on the Pharmaceuticals &#038; Drugs industry. The company is involved in the development, manufacturing, and distribution of pharmaceutical products. Its product portfolio includes a range of drugs and formulations aimed at addressing various medical needs.<\/p>\n<p>As a micro-cap company, Pharmaids Pharmaceuticals faces challenges in scaling its operations and achieving profitability. The competitive landscape of the Pharmaceuticals &#038; Drugs industry requires continuous innovation and strategic positioning to capture market share.<\/p>\n<p>Despite its current financial challenges, Pharmaids Pharmaceuticals remains a player in the industry, with potential opportunities for growth and expansion in the future.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Pharmaids_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Pharmaids Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/pharmaid\/pharmaids-pharmaceuticals-ltd-share-price-today\">Pharmaids Pharmaceuticals Ltd. (PHARMAID) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top gainers lists and related market analysis.<\/p>\n<p>Investors can track the Pharmaids Pharmaceuticals Share Price on Univest for real-time updates and insights. Univest provides access to live share prices, technical indicators, fundamental ratios, and shareholding patterns. Stay informed about the latest market trends and developments by following Pharmaids Pharmaceuticals on Univest.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Pharmaids_Pharmaceuticals\"><\/span><strong>What is the current share price of Pharmaids Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current share price of Pharmaids Pharmaceuticals is Rs 34.9, reflecting an 8.39% increase from the previous close of Rs 32.2. The stock moved 8.39% during the session. The intraday range extended from Rs 33.05 to Rs 36.04.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Pharmaids_Pharmaceuticals_share_price_rise_today\"><\/span><strong>How much did Pharmaids Pharmaceuticals&#39; share price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pharmaids Pharmaceuticals&#39; share price rose by 8.39% today, marking a significant gain in the micro-cap category. The stock moved 8.39% during the session. The intraday range extended from Rs 33.05 to Rs 36.04.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Pharmaids_Pharmaceuticals\"><\/span><strong>What is the market capitalisation of Pharmaids Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pharmaids Pharmaceuticals has a market capitalisation of Rs 114.66 crore, positioning it within the micro-cap category. The company operates in the Healthcare sector. Its P\/E ratio is -10.51x. ROE is 1.1% and ROCE is 1.04%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Pharmaids_Pharmaceuticals\"><\/span><strong>What is the P\/E ratio of Pharmaids Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio of Pharmaids Pharmaceuticals is -10.51, indicating that the company is currently not profitable. The company trades at a P\/E ratio of -10.51x. Its P\/B ratio is 2.38x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PB_ratio_of_Pharmaids_Pharmaceuticals\"><\/span><strong>What is the P\/B ratio of Pharmaids Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/B ratio of Pharmaids Pharmaceuticals is 2.38, which is above the industry median of 1.86. The company trades at a P\/E ratio of -10.51x. Its P\/B ratio is 2.38x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Pharmaids_Pharmaceuticals_ROE_compare_to_the_industry\"><\/span><strong>How does Pharmaids Pharmaceuticals&#39; ROE compare to the industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pharmaids Pharmaceuticals&#39; ROE is 1.1%, which is below the industry median of 10.59%, indicating lower profitability. ROE stands at 1.1%. ROCE stands at 1.04%. The relevant peer median ROE is 10.59%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Pharmaids_Pharmaceuticals_market_cap_compare_to_its_peers\"><\/span><strong>How does Pharmaids Pharmaceuticals&#39; market cap compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pharmaids Pharmaceuticals&#39; market cap of Rs 114.66 crore is below the industry median of Rs 145.72 crore, highlighting its position in the micro-cap category. The company operates in the Healthcare sector.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmaids Pharmaceuticals Ltd. Share Price rises to Rs Rs 34.9. marking a 8.39% rise today. clearing the 8.1% threshold for Micro Cap stocks. Market cap stands<\/p>\n","protected":false},"author":29,"featured_media":187939,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-187941","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["187939"],"rank_math_title":["Pharmaids Pharmaceuticals Share Price Rises 8.39% Today"],"rank_math_description":["Pharmaids Pharmaceuticals Share Price rises 8.39% today. Explore price action, technicals, fundamentals, and sector analysis for informed insights."],"rank_math_focus_keyword":["Pharmaids Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Pharmaids_Pharmaceuticals_Ltd_PHARMAID_Pharmaids_Pharmaceuticals_Share_Price_Rises_839_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/187941","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=187941"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/187941\/revisions"}],"predecessor-version":[{"id":187946,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/187941\/revisions\/187946"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/187939"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=187941"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=187941"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=187941"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}